Key facts
- This page summarizes James G. Marken's Form 4 filing for ANI PHARMACEUTICALS INC (ANIP).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 11 Jun 2024, 16:51.
James G. Marken - 07 Jun 2024 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)
- Reporting relationship
- SVP OPS & PROD DEV
- Issuer ticker
- ANIP
- Reported as of
- 07 Jun 2024
- Net transaction value
- -$750,590
- SEC form
- 4
- Accepted by SEC
- 11 Jun 2024, 16:51:43 UTC
- Prior SEC filing
- 11 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ James G. Marken, by attorney-in-fact Meredith W. Cook
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
James G. Marken filed Form 4 for ANI PHARMACEUTICALS INC (ANIP) on 11 Jun 2024.
Change
- Previous filing in this sequence was filed on 11 Apr 2024.
- Current net transaction value: -$750,590.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANIP
transaction
Common Stock
Options Exercise
- Transaction value
- $358,948
- Shares
- +7,250
- Change %
- +6.2%
- Price
- $49.51
- Shares after
- 123,616
- Date
- 07 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
ANIP
transaction
Common Stock
Options Exercise
- Transaction value
- $302,418
- Shares
- +5,300
- Change %
- +4.3%
- Price
- $57.06
- Shares after
- 128,916
- Date
- 07 Jun 2024
- Ownership
- Direct
ANIP
transaction
Common Stock
Tax liability
- Transaction value
- $750,590
- Shares
- -11,087
- Change %
- -8.6%
- Price
- $67.70
- Shares after
- 117,829
- Date
- 07 Jun 2024
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANIP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $358,948
- Shares
- -7,250
- Change %
- -100%
- Price
- $49.51
- Shares after
- 0
- Date
- 07 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,250
- Exercise price
- $49.51
- Footnotes
- F3
ANIP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $302,418
- Shares
- -5,300
- Change %
- -100%
- Price
- $57.06
- Shares after
- 0
- Date
- 07 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,300
- Exercise price
- $57.06
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The number of shares beneficially owned by the reporting person is amended in this Form 4 to correct an administrative error in a Form 4 filed on March 9, 2023, which misreported that 1,951 shares were withheld on March 7, 2023 to cover taxes on a vesting of shares on that date, when 1,591 shares were withheld. In correcting this administrative error, the number of shares beneficially owned by the reporting person reflects an increase of 360 shares.
Footnote F2
The shares were sold in multiple trades at prices ranging from $67.64 to $68.10. The price reported above reflects the weighted average sales price.
Footnote F3
25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.
Footnote F4
25% of the total options vested on each of April 6, 2019, April 6, 2020, April 6, 2021, and April 6, 2022.